{
    "N/R/U": null,
    "Applicant": "Organon USA Inc., a subsidiary of Merck & Co., Inc.",
    "BLA Number": "020580",
    "Proprietary Name": "Cotazym",
    "Proper Name": "pancrelipase",
    "BLA Type": "351(a)",
    "Strength": "8,000USP UNITS; 30,000USP UNITS; 30,000USP UNITS",
    "Dosage Form": "Capsule, Delayed Release",
    "Route of Administration": "Oral",
    "Product Presentation": null,
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "December 09, 1996",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "2193",
    "Product Number": "001",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "pancrelipase",
            "drugbank_id": "https://go.drugbank.com/drugs/DB00085"
        }
    ]
}